American Society of Hirudotherapy

Unani treatment and leech therapy saved the diabetic foot of a patient from amputation

Zaidi SM (2014) · International Wound Journal · n=1

RCT evidence detailTrial reference
Sample size of this trial compared with other Diabetic Peripheral Neuropathy (Investigational Adjunct) trialsZaidi SM 20141Akalın Ç 20201
This trial (highlighted) by sample size alongside other indexed Diabetic Peripheral Neuropathy (Investigational Adjunct) trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-patient case study (60-year-old woman with grade 5 diabetic foot ulcer facing imminent amputation; Jamia Hamdard, New Delhi, India)
Sample size (n)
1
Intervention
Unani blood purifier + deobstruent medication, unripe papaya wound dressing, hirudotherapy weekly for ~3.5 months
Comparator
Conventional treatment trajectory toward amputation
Primary endpoint
Wound healing, pain control, limb salvage from amputation
Primary result
Pain score decreased from 80mm to 0-10mm on 100mm VAS within 20 days; necrotic areas disappeared and wound completely healed within 3.5 months; limb salvaged from imminent amputation
Follow-up duration
3.5 months active treatment + observation

Key Findings

  • Limb salvage achieved in grade 5 diabetic foot facing imminent amputation
  • Pain reduction from 80mm to 0-10mm VAS within 20 days
  • Complete wound healing within 3.5 months
  • Combination Unani + hirudotherapy + papaya dressing protocol
  • No adverse events reported

Limitations

  • Single patient - no generalizable conclusions possible
  • Cannot separate effects of Unani medicine vs hirudotherapy vs papaya
  • No long-term follow-up reported
  • Subjective pain assessment
  • Publication bias toward dramatic case successes

Clinical Implications

Zaidi 2014 provides hypothesis-generating evidence for hirudotherapy as adjunct in advanced diabetic foot ulcer management. For US clinicians under K040187, this Indian Unani-medicine case suggests potential utility in non-healing wounds but the multi-modal intervention prevents causal attribution. Provides motivation for prospective trials of leech adjunct in diabetic foot ulcers.

Related Trials

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.